|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/14 | |
| A61K 31/4184 | |||
| A61K 31/4164 | |||
| A61P 31/14 |
| (11) | Patento numeris | 2678334 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12716757.5 |
| Europos patento paraiškos padavimo data | 2012-02-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/026456 |
| Data | 2012-02-24 |
| (87) | Numeris | WO 2012/116257 |
| Data | 2012-08-30 |
| (30) | Numeris | Data | Šalis |
| 201161446800 P | 2011-02-25 | US |
| (72) |
DEGOEY, David A., US
KATI, Warren M., US
HUTCHINS, Charles W., US
DONNER, Pamela L., US
KRUEGER, Allan C., US
RANDOLPH, John T., US
PATEL, Sachin V., US
MATULENKO, Mark A., US
KEDDY, Ryan G., US
JINKERSON, Tammie K., US
LIU, Dachun, US
PRATT, John K., US
ROCKWAY, Todd W., US
MARING, Clarence J., US
HUTCHINSON, Douglas H., US
FLENTGE, Charles A., US
WAGNER, Rolf, US
BETEBENNER, David A., US
SARRIS, Kathy, US
WOLLER, Kevin R., US
CARROLL, William A., US
GAO, Yi, US
|
| (73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
| (54) | ANTI-VIRAL COMPOUNDS |
| ANTI-VIRAL COMPOUNDS |